Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Torrent Expands its Voluntary Recall of Losartan

americanpharmaceuticalreviewJanuary 24, 2019

Tag: Torrent , Losartan , NDEA , FDA

PharmaSources Customer Service